Cite
Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia
MLA
Michalle Soudack, et al. “Elevated IgM Levels as a Marker for a Unique Phenotype in Patients with Ataxia Telangiectasia.” BMC Pediatrics, vol. 18, no. 1, June 2018, pp. 1–6. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....918f0134fbccef74a7d0eb4e23c9149a&authtype=sso&custid=ns315887.
APA
Michalle Soudack, Avishay Lahad, Raz Somech, Alexander Krauthammer, Ifat Sarouk, Lior Goldberg, Batia Weiss, & Itai M. Pessach. (2018). Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia. BMC Pediatrics, 18(1), 1–6.
Chicago
Michalle Soudack, Avishay Lahad, Raz Somech, Alexander Krauthammer, Ifat Sarouk, Lior Goldberg, Batia Weiss, and Itai M. Pessach. 2018. “Elevated IgM Levels as a Marker for a Unique Phenotype in Patients with Ataxia Telangiectasia.” BMC Pediatrics 18 (1): 1–6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....918f0134fbccef74a7d0eb4e23c9149a&authtype=sso&custid=ns315887.